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Perinatal tuberculosis is an uncommon condition but with a high mortality and a challenging 
diagnosis. We present four cases of perinatal tuberculosis managed between 1991-2014 in a 
Spanish Tertiary Hospital. The infection should be considered in patients with progressive 
respiratory symptoms and with a poor response to conventional antibiotic therapy, especially in 
those with positive epidemiologic risk. Bronchoscopy can be a useful tool for diagnosis.  
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INTRODUCTION 
Tuberculosis (TB) continues to be one of the most prevalent infections worldwide. 
Perinatal TB is uncommon and its diagnosis and management remains a challenge
1
. The clinical 
manifestations in these patients are non-specific and manifest in a variety of ways. The diagnosis 
is based on two principles: the identification of Mycobacterium tuberculosis (MT) in cultures or 
a positive gene amplification/PCR from patient samples, and by imaging. There is limited data 
about therapeutic regimens at this early age
1-4
, therefore treatment follows the same guidelines as 
that of older children. 
Case 1 
45-day-old premature infant (32 weeks gestation), from Morocco, transferred to our 
hospital after a slow resolution of a respiratory infection, with no response to antibiotics. Chest 
radiograph showed several areas of consolidation (figure 1, 1A). He required increasing 
respiratory support including intubation and assisted ventilation. Flexible bronchoscopy (FB) and 
bronchoalveolar lavage (BAL) were performed that revealed extrinsic compression of the 
airway. Chest CT showed numerous cavitating nodules (figure 1,1B). Tuberculin testing (TST) 
was 3 mm and QuantiFERON-TB Gold® test (QFT) was positive. The BAL smear microscopy 
showed acid-fast bacilli (AFB), confirmed by MT PCR. Treatment was initiated (isoniazid, 
rifampicin, pyrazinamide and ethambutol) along with systemic steroids. MT culture from the 
BAL was positive and the organism was pan-susceptible. On contact tracing, the mother was 
found to have symptoms and tuberculosis was confirmed. The infant made a good recovery. 
 
Case2 
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A 5-month-old infant, of Moroccan origin, presented with a 3-month history of persistent 
cough, progressive shortness of breath, intermittent fever and failure to thrive. The infant was 
referred to our pediatric surgery department with a suspected diagnosis of congenital lobar 
emphysema (figure 1.2A). A chest CT excluded this (figure 1,2B). He underwent a FB which 
showed granulation tissue. BAL and gastric aspirate smear were negative, but MT PCR and 
culture were positive. TST was <5 mm. The mother had findings compatible with TB disease. 
Treatment was established with three drugs (isoniazid, rifampicin and pyrazinamide) as per 
current guidelines along with steroids the first month. He made a good recovery. 
Case 3 
Ex-preterm infant, from Morocco, transferred to our hospital at 20 hours of life. Intubated 
and ventilated after delivery, diagnosed with acute respiratory distress secondary to hyaline 
membrane disease. He made a clinical improvement and was weaned from ventilatory support. 
However, he had persistent tachypnea, intermittent low grade fever and sequential radiographs 
showing persistent atelectasis of superior right lobe (figure 1,3A). FB and BAL were performed 
at three months of age, showing granulation tissue. Bacilloscopy was negative, but MT culture in 
BAL and gastric aspirate was positive. TB treatment was initiated with systemic steroids for a 
month. His recovery was satisfactory, although residual atelectasis persisted after completion of 
treatment (figure 1, 3B). 
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Case 4 
A 2-month-old-infant, transferred to our hospital from Morocco, due to persistent 
tachypnea since early days of life, and progressive respiratory failure. No evidence of 
parenchymal abnormalities on chest radiograph. FB and BAL were performed, showing 
moderate obstruction of the distal tracheal lumen and principal left bronchi with no evidence of 
granulation tissue or caseum. Bacilloscopy and MT culture of BAL were negative. CT scan 
showed mediastinal-subcarinal adenopathies. On contact tracing, mother’s investigations were 
compatible with TB disease, strengthening the decision to begin TB treatment for the infant. 
Systemic steroids were added during the first month. The infection resolved without sequelae. 
DISCUSSION  
Perinatal TB refers to an infection with MT that occurs in utero, at birth, or during the 
early newborn period
1
. In 1994, Cantwell and collaborators, defined the diagnostic criteria of 
“congenital TB”5,6. These criteria required at least one of the following: onset of symptoms in the 
first week of life, a primary liver lesion or a caseous liver granuloma, tuberculous infection of the 
placenta or of the maternal genital tract
1,2-6
.  
Perinatal TB is an uncommon infection and its incidence is difficult to determine
2,3
. To 
date, there have been approximately over 300 reported cases published in the English language
4
. 
Neonates are extremely vulnerable to TB, due to the immaturity of the immune system. 
There are three routes of transmission: the hematologic path, via the umbilical vein, producing 
primary lesions in the liver or in the lung; by in utero aspiration of infected fluids, with primary 
lesions in the lung or digestive tract (congenital TB); postpartum by inhalation or ingestion from 
an infectious contact
1,3,6,7
.  
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According to the literature, the symptoms in newborns usually occur from the second or 
third week of life, although its onset may be delayed until the fourth month of life
1 
(as in cases 2 
and 3). Clinical manifestations include hepatosplenomegaly (65-100 %), respiratory distress (70 
%), fever (50-100 %), lymphadenopathy (38 %), poor weight gain, irritability and lethargy (20-
40 %)
3,6,7
. TB should be considered in all cases of infants presenting with progressive pneumonia 
and poor response to conventional antibiotic treatment (cases 1 and 3)
1,7,8
. 
The diagnosis of TB in the infant is complicated. As soon as it is suspected, a tuberculin 
skin test and/or IGRAs (Interferon Gamma Release Assay) is indicated, along with a chest 
radiograph and cultures (gastric/broncho-aspirates or bronchoalveolar lavage and CSF)
7,8
. 
Tuberculin skin testing does not have adequate sensitivity in infants younger than 6 months 
because of their immunologic immaturity. IGRAs are an alternative diagnostic test, although 
there are doubts about its validity in newborns due to lower production of IFN-γ. Individual 
studies have suggested worse sensitivity and higher rates of indeterminate results in children <5 
years of age compared with older ones
7,9
. In a recent meta-analysis assessing the diagnostic 
accuracy of IGRAs compared with TST, similar sensitivity was shown for both
9
. MT culture of 
gastric aspirate material establishes definitive diagnosis, with higher yield (70 %) in newborns 
than in infants or older children (30-40 %)
1,7
. 
Chest radiograph usually shows variable pathologic findings, depending on the 
transmission mechanism and time course of the disease. Different radiographic patterns include: 
(i) miliary or interstitial pattern (approximately 50 % of patients
3,8,10
; (ii) pneumonic forms; (iii) 
nodal forms; (iv) cavitated forms (although rare in children, it is referred to as "progressive 
primary TB" as seen in case 1) and (v) endobronchial forms (like cases 2 and 3)
8
. At the 
beginning of the infection, radiograph may be normal, and CT should be considered. 
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FB for perinatal TB might be indicated for the following reasons; the need for collection 
of respiratory samples; assessment of unclarified interstitial lung disease with poor response to 
conventional treatment (case 3); staging of endobronchial TB; and to aid decisions regarding the 
need for systemic steroids
8
. In all of our cases bronchial compression or a bronchial fistula were 
observed; hence, the decision to initiate steroids. 
In the evaluation of a neonate with suspected TB, it is necessary to perform screening for 
other congenital infections and staging of the disease with diagnostic tests such as brain and 
abdomen ultrasound (MRI brain could be required) and fundoscopy
1,7
. 
Once the initial investigations are complete, treatment should be initiated. It must be 
based on the sensitivity of the maternal strain, if known
7,8
. The recommended treatment for 
newborns and infants includes 4 drugs for 2 months: isoniazid, rifampin, pyrazinamide and 
streptomycin/amikacin or ethambutol; followed by 4-10 months with only two drugs (isoniazid 
and rifampicin) depending whether the infant has pulmonary TB or tuberculous peripheral 
lymphadenitis (6 months total treatment)
11
 or disseminated disease with CNS involvement (12 
months)
7,11
. As perinatal TB is not a common disease, there are currently no therapeutic trials to 
determine the optimal type or duration of treatment, although an accepted regimen is 
maintenance treatment for 6-12 months, extending to 18-24 if resistance is observed
1,7
. 
Corticosteroid therapy is not routinely indicated, but is recommended in cases of central nervous 
system, miliary TB, pleural or pericardial or endobronchial involvement. The drug of choice is 
prednisone 1-2mg/kg/day oral for 4-6 weeks with gradual weaning
7,11
.
 
Since there are no reported cases of TB transmission through breastmilk
4
, breastfeeding 
is only contraindicated in mothers with an active lesion in the breast
1
. 
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Figure legend: 
Figure 1. Radiological findings. Case 1: 1A. Chest radiograph: RUL condensation and RLL and 
ML. 1B. Chest CT: multiple cavitated parenchymal nodules. Case 2. 2A. Chest radiograph: right 
lung hyperinflation with collapsed RUL, ML and RLL with mediastinal shift to the left. 2B. 
Chest CT: right paravertebral adenopathic conglomerate with calcifications. Case 3. 3A. Chest 
radiograph (diagnosis): interstitial pattern (hyaline membrane disease) and atelectasis RUL. 3B. 
Chest radiograph: residual atelectasis in RUL (end of treatment). (RUL = Right Upper Lobe; 
LUL = Left Upper Lobe; ML = Middle Lobe; RLL = Right Lower Lobe; LLL = Left Lower 
Lobe). 
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